60 Degrees Pharmaceuticals, INC

60 Degrees Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing new small molecule therapeutics for the prevention and treatment of infectious diseases. Their mission is to safeguard lives by discovering, developing, and distributing best-in-class medicines, particularly for neglected tropical diseases where critical research gaps exist. The company's lead therapeutic, ARAKODA® (tafenoquine), is an FDA-approved malaria preventative treatment marketed in the U.S. and is being investigated for additional indications such as babesiosis, fungal, and viral diseases.

60 Degrees Pharmaceuticals is committed to an open innovation approach, collaborating with leading research institutions to reduce the time, cost, and risk associated with drug discovery and development. They are driven by a vision to become a trusted leader in changing the practice of malaria prevention and creating innovative solutions to combat life-threatening infectious diseases globally.

60 Degrees Pharmaceuticals is a specialty pharmaceutical company dedicated to safeguarding lives by discovering, developing, and commercializing new medicines for the treatment and prevention of infectious diseases, particularly those with critical research gaps. They strive to create innovative, potentially life-saving therapies that significantly impact the quality of life for individuals affected by infectious diseases worldwide.

60 Degrees Pharmaceuticals promotes a culture of innovation and collaboration, driven by a shared passion for developing life-saving medicines to address global health challenges. The company embraces an open innovation approach, partnering with leading research institutions and leveraging the expertise of its diverse and experienced leadership team to achieve its goals. This collaborative environment fosters a spirit of teamwork, dedication, and a strong commitment to making a meaningful impact on the world.